Immunogenicity of heterologous prime-boost regimens involving recombinant adenovirus serotype 11 (Ad11) and Ad35 vaccine vectors in the presence of anti-ad5 immunity.

Lemckert, Angelique A C; Sumida, Shawn M; Holterman, Lennart; Vogels, Ronald; Truitt, Diana M; Lynch, Diana M; Nanda, Anjali; Ewald, Bonnie A; Gorgone, Darci A; Lifton, Michelle A; Goudsmit, Jaap; Havenga, Menzo J E; Barouch, Dan H

Lemckert, Angelique A C; Sumida, Shawn M; Holterman, Lennart; Vogels, Ronald; Truitt, Diana M; Lynch, Diana M; Nanda, Anjali; Ewald, Bonnie A; Gorgone, Darci A; Lifton, Michelle A; Goudsmit, Jaap; Havenga, Menzo J E; Barouch, Dan H.

Affiliation

Lemckert AA; Crucell Holland B. V, Leiden, The Netherlands.

J Virol ; 79(15): 9694-701, 2005 Aug.

Article in En | MEDLINE | ID: mdl-16014931

Subject(s)

Adenoviruses, Human/immunology; Genetic Vectors/immunology; Reassortant Viruses/immunology; Viral Vaccines/immunology; Animals; Antibody Formation; Cross Reactions; Drug Evaluation, Preclinical; Gene Products, gag/genetics; Genetic Therapy; Immunity, Cellular; Immunization, Secondary; Injections, Intramuscular; Mice; Mice, Inbred C57BL; Simian Immunodeficiency Virus/genetics; Vaccines, Synthetic/immunology; Viral Vaccines/administration & dosage

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Viral Vaccines / Adenoviruses, Human / Reassortant Viruses / Genetic Vectors Type of study: Risk_factors_studies Limits: Animals Language: En Journal: J Virol Year: 2005 Type: Article Affiliation country: Netherlands

Fulltext

XML

PubMed Links

Search on Google